Investors
- Creating value for our company, our shareholders and society
Investors
We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
Novartis Investors Event Calendar
View recent presentations and learn more about upcoming events.
June 22, 2021
Iptacopan (LNP023) update
Novartis COVID-19 Information Center
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
ESG Updates: Apr 28, 2021 (PDF 0.3 MB) | Jan 27, 2021 (PDF 0.5 MB) | Oct 28, 2020 (PDF 0.5 MB) | July 24, 2020 (PDF 0.6 MB)
Latest updates: Novartis Enterprise Risk Management (PDF 0.2 MB) | Materiality Assessments Webinars
Novartis receives FDA Breakthrough Therapy designation for investigational 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer (mCRPC)
Novartis Clinical Pipeline
Our broad portfolio and strong pipeline help us offset the recurring impact of patent expirations for key products.
For questions about investor relations or the share registry, please contact our team.
Novartis AG
Lichtstrasse 35
CH-4056 Basel, Switzerland